Condition
Ductal Adenocarcinoma of the Pancreas clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ductal Adenocarcinoma of the Pancreas clinical trials that are recruiting, at sites in 2 countries (most in Spain (1), United States (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
More frequent VCN-01 with standard chemo in metastatic pancreatic cancer
This study tests a new dosing schedule of VCN-01 with gemcitabine and nab-paclitaxel to see if it’s safe and tolerable in adults with newly diagnosed, metastatic pancreatic cancer.
-
Using nanoparticles with MR-guided radiation therapy for lung and pancreatic tumors
This study is testing if a new type of nanoparticle can make radiation therapy more effective for people with lung tumors and advanced pancreatic cancer.
Related topics
Quick answers
How many Ductal Adenocarcinoma of the Pancreas clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Spain (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.